Hello. I had my first blood test yesterday in readiness for starting Abemaciclib (my doctor appointment for this is Friday).
I have just read some disclosed guidelines which state ribociclib is now the preferred ADK 4/6 inhibitor for early stage HER2 negative. I’m doing lots of research to find out why but just wondered if anyone had any thoughts/experience of this themselves.
So far I have found the percentage outcomes as follows-
Abemaciclib- 15.8% reduction in risk of death.
Ribociclib- 25.1% reduction in risk of death.
